The Wolverine Stack: How to Launch a BPC-157 and TB-500 Recovery Brand

A guide to the Wolverine Stack — the BPC-157 and TB-500 peptide combination widely used for accelerated injury recovery and tissue repair. Covers the science, the synergy, who it is for, and how to build a recovery telehealth brand around it.

C
Chad H.
Updated May 31, 2026 5 min read
On this page
Disclaimer: This content is intended for healthcare professionals evaluating practice management solutions. It does not constitute medical advice.

In athlete communities, the Wolverine Stack has become shorthand for one thing: healing what should not be healable. Torn tendons. Chronic shoulder issues. Nagging injuries that two years of physical therapy could not resolve.

The name comes from the Marvel character whose superpower is accelerated healing. The stack is BPC-157 and TB-500 — two peptides that target tissue repair through distinct but synergistic mechanisms. This guide covers the science, the clinical application, and how to build a recovery telehealth brand around it.

How the Stack Works

BPC-157: The Local Repair Signal

BPC-157 is a synthetic pentadecapeptide derived from a protein in gastric juice. Its primary mechanism of action involves upregulating the expression of growth hormone receptors in injured tissue — essentially making damaged cells more responsive to the repair signals they are already receiving.

Beyond receptor upregulation, BPC-157 promotes tendon fibroblast proliferation (the cells responsible for building tendon matrix), modulates nitric oxide production (affecting blood flow to injured areas), and has anti-inflammatory effects at the site of damage.

The key clinical research on BPC-157 comes primarily from Sikiric and colleagues at the University of Zagreb, with studies demonstrating accelerated healing in animal models of Achilles tendon injury, anterior cruciate ligament injury, and muscle crush injuries (Sikiric et al., Current Pharmaceutical Design, 2018).

TB-500: The Systemic Mobilizer

TB-500 works differently. It promotes cell migration — the movement of repair cells (endothelial cells, fibroblasts, keratinocytes) to injury sites. This is mediated through its interaction with actin, a protein involved in cell motility.

TB-500 also stimulates angiogenesis (new blood vessel formation), which is critical for healing in avascular or poorly vascularized tissue like tendons and cartilage. One of the reasons chronic tendon injuries do not heal well is poor blood supply. TB-500 directly addresses this limitation.

The compound has a systemic distribution profile, meaning it reaches multiple injury sites even when administered subcutaneously at a single location. This is valuable for athletes with multiple concurrent injuries.

The Synergy

BPC-157 and TB-500 work through complementary mechanisms:

  • BPC-157 works locally (maximally effective near the injury site) while TB-500 works systemically
  • BPC-157 primarily affects receptor expression and fibroblast activity; TB-500 primarily affects cell migration and angiogenesis
  • Together, they address both the local repair response and the systemic mobilization required to bring repair resources to injured tissue

This synergy is why practitioners who use both report better outcomes than with either peptide alone — particularly for chronic injuries that have partial but incomplete healing.

Who This Brand Is For

The Wolverine Stack is for a specific type of patient: the active person who has an injury that conventional medicine has not solved.

Target patient profiles:

  • CrossFit athletes with rotator cuff issues, wrist injuries, or hip flexor problems that limit their training
  • Powerlifters with chronic elbow, shoulder, or hip joint degradation
  • Endurance athletes (runners, cyclists, triathletes) with tendon injuries like plantar fasciitis, Achilles tendinopathy, or IT band syndrome
  • Team sport athletes (basketball, soccer, football) dealing with chronic joint pain or post-surgery incomplete recovery
  • Older adults who are active but healing much more slowly than they did at 30

What unites these patients is that they have tried the standard options and they are still not fully healed. They are motivated, informed, and willing to invest significantly in a solution that works.

Building the Brand

The Wolverine Stack brand has built-in positioning: it is for serious athletes and active adults who demand real recovery. The brand identity should reflect that orientation — performance-focused, clinically credible, and specific to the training community.

Your brand wrapper includes the name, visual identity, content approach, and the community you serve. The clinical infrastructure — prescribing physicians, compounding pharmacy, patient portal, intake forms, HIPAA compliance — comes from the platform.

Program structure:

  • 8-week acute recovery protocol (higher dose, daily injection)
  • 12 to 16-week comprehensive recovery protocol
  • Maintenance protocol after primary recovery

Revenue model:

  • 8-week acute protocol: $399 to $499 (one-time payment or 2-month subscription)
  • Full 16-week protocol: $279 to $349 per month
  • Operator net: $140 to $200 per patient per month

Content Strategy for a Recovery Brand

A recovery-focused peptide brand generates content from a natural well:

Injury-specific educational content. Articles about rotator cuff recovery, Achilles tendinopathy, chronic knee pain, and similar high-search topics attract exactly the patients who need the stack. These rank well in search because they are specific, helpful, and underserved by conventional health content.

Protocol education. How to administer BPC-157 subcutaneous injections safely, how to time dosing around training, what to expect at week 2, 4, and 8.

Training programming alongside recovery. If you are a coach or trainer, programming that integrates with a BPC-157/TB-500 recovery protocol creates a fully differentiated product.

Before-and-after outcomes. Movement quality and pain level improvements are measurable and photographable, providing strong social proof (with appropriate FTC disclosure and patient consent).

The Next Step

If you coach athletes or serve active adults with injury challenges, the Wolverine Stack brand is one of the most specific and differentiated telehealth products you can launch. The combination of strong clinical rationale, underserved patient need, and high patient willingness to pay creates favorable unit economics.

Learn more about building a recovery peptide brand with Karpa Health.

For more context on closely related topics, read BPC-157 recovery brand guide, BPC-157 prescription guide, and peptide body composition brand guide.

Frequently Asked Questions

What is the Wolverine Stack?
The Wolverine Stack is a combination of BPC-157 and TB-500 (thymosin beta-4), two peptides that target tissue repair through complementary mechanisms. BPC-157 accelerates healing of tendons, ligaments, and gut tissue by upregulating growth factor receptor expression and stimulating fibroblast activity at the injury site. TB-500 promotes systemic cell migration, reduces inflammation, and supports blood vessel formation (angiogenesis) to restore circulation to damaged tissue. Together, they address healing from multiple pathways simultaneously, which is why the stack produces faster and more complete recovery than either peptide alone.
What is TB-500 and is it different from thymosin beta-4?
TB-500 is a synthetic analog of thymosin beta-4, a naturally occurring peptide found in high concentrations in platelets and wound fluid. Thymosin beta-4 promotes actin polymerization (essential for cell movement and repair), reduces inflammation, and stimulates angiogenesis. TB-500 is specifically the fragment of thymosin beta-4 that retains these biological activities. It is commonly used in equine sports medicine and has a significant body of preclinical research supporting tissue repair applications in humans.
What injuries does the Wolverine Stack help with?
The Wolverine Stack is most commonly used for tendon and ligament injuries (rotator cuff, ACL/MCL, Achilles, patellar tendon), chronic joint pain, post-surgical healing, muscle tears, and general connective tissue recovery. The combination is particularly valued for injuries that have failed to fully heal with standard rest, physical therapy, and anti-inflammatory approaches. Athletes who need to maintain training while recovering from a nagging injury often find the stack allows them to continue at modified intensity while the tissue heals.
How long does a Wolverine Stack protocol take?
Standard Wolverine Stack protocols run 8 to 16 weeks. Most patients report initial effects within 2 to 4 weeks (reduced pain and inflammation, improved range of motion). Full structural tissue repair continues over the full protocol duration. Many athletes run a second cycle after a period off, particularly for injuries that showed progress but were not fully resolved in the first round.
Can I launch a Wolverine Stack brand without a medical license?
Yes. The brand operator does not prescribe or provide medical advice. A turnkey telehealth platform provides licensed physicians who evaluate each patient, determine whether BPC-157 and TB-500 are appropriate, and write the prescription. The operator manages the brand, content, and patient acquisition. The platform handles all clinical and regulatory compliance.
What does a Wolverine Stack program cost to run and what can I charge?
Wolverine Stack programs typically sell for $279 to $399 per month, reflecting the cost of two peptide compounds. Platform and pharmacy costs run $110 to $140 per patient per month. Operator net margin runs $140 to $200 per patient per month. Patients who enroll in recovery-specific programs often convert to maintenance peptide programs after the acute recovery phase, extending the long-term relationship.

Related Program

Ready to launch your Peptide Therapy Program?

See How It Works
C

Written by

Chad H.

Co-founder of Karpa Health. Building turnkey telehealth infrastructure for clinicians and entrepreneurs launching cash-pay specialty programs.

Learn more about Karpa →

Related Articles

Ready to Launch Your Peptide Program?

See how Karpa's turnkey platform handles prescribing, pharmacy fulfillment, and compliance so you can focus on growth.

Launch Your Program